Japanese (NIKKEI) Pharma Industry Analysis
- 7D0.9%
- 3M-8.4%
- 1Y-17.2%
- YTD-5.3%
Over the last 7 days, the Pharma industry has remained flat, although notably Nippon Shinyaku gained 3.4%. Unfortunately though, the industry is down 17% over the past 12 months.
Industry Valuation and Performance
Has the Japanese Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Wed, 26 Jan 2022 | JPÂ¥33.0t | JPÂ¥12.5t | JPÂ¥1.6t | 17.3x |
| Fri, 24 Dec 2021 | JPÂ¥34.3t | JPÂ¥12.5t | JPÂ¥1.6t | 18x |
| Sun, 21 Nov 2021 | JPÂ¥35.5t | JPÂ¥12.5t | JPÂ¥1.6t | 18.9x |
| Tue, 19 Oct 2021 | JPÂ¥36.1t | JPÂ¥12.2t | JPÂ¥1.5t | 18.3x |
| Thu, 16 Sep 2021 | JPÂ¥37.8t | JPÂ¥12.3t | JPÂ¥1.5t | 18.5x |
| Sat, 14 Aug 2021 | JPÂ¥35.6t | JPÂ¥12.3t | JPÂ¥1.5t | 17.3x |
| Wed, 09 Jun 2021 | JPÂ¥35.3t | JPÂ¥11.9t | JPÂ¥1.4t | 16.9x |
| Tue, 02 Mar 2021 | JPÂ¥36.4t | JPÂ¥12.0t | JPÂ¥1.3t | 21.9x |
| Fri, 04 Dec 2020 | JPÂ¥38.3t | JPÂ¥12.0t | JPÂ¥1.2t | 24.7x |
| Mon, 07 Sep 2020 | JPÂ¥38.2t | JPÂ¥12.0t | JPÂ¥1.3t | 24.6x |
| Sun, 31 May 2020 | JPÂ¥40.8t | JPÂ¥12.0t | JPÂ¥1.2t | 23.6x |
| Wed, 04 Mar 2020 | JPÂ¥33.3t | JPÂ¥11.9t | JPÂ¥1.2t | 20.2x |
| Sat, 07 Dec 2019 | JPÂ¥35.2t | JPÂ¥11.5t | JPÂ¥1.2t | 20.5x |
| Tue, 10 Sep 2019 | JPÂ¥29.9t | JPÂ¥11.0t | JPÂ¥1.2t | 18.7x |
| Mon, 03 Jun 2019 | JPÂ¥28.8t | JPÂ¥10.5t | JPÂ¥1.2t | 18.6x |
| Thu, 07 Mar 2019 | JPÂ¥32.7t | JPÂ¥10.1t | JPÂ¥1.1t | 22.7x |
20.5x
Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 20.4x. It appears they believe that earnings will grow in-line with historical growth rates.
Past Earnings Growth: The earnings for companies in the Pharmaceuticals industry have grown 13% per year over the last three years, and revenues for these companies have grown 7.4% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Japanese Pharma industry?
| Pharma | 0.88% | |
Industry PE: Investors are most optimistic about the Pharma industry even though it's trading below its 3-year average PE ratio of 20.4x. This is likely because analysts are expecting annual earnings growth of 12%, which is higher than its past year's earnings growth of 8.3% per year.
Forecasted Growth: Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 12% over the next 5 years. This is better than it's past earnings growth rate of 8.3% per year.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4516 Nippon Shinyaku | JPÂ¥7.67k | 3.4% +JPÂ¥16.8b | 1.9% | PE17.7x | |
| 4519 Chugai Pharmaceutical | JPÂ¥3.70k | 0.2% +JPÂ¥13.2b | -33.7% | PE23.7x | |
| 4581 Taisho Pharmaceutical Holdings | JPÂ¥5.51k | 2.8% +JPÂ¥12.3b | -19.0% | PE91.6x | |
| 4536 Santen Pharmaceutical | JPÂ¥1.32k | 1.5% +JPÂ¥7.6b | -22.8% | PE72.4x | |
| 4528 Ono Pharmaceutical | JPÂ¥2.73k | 0.4% +JPÂ¥5.7b | -11.4% | PE16.4x |